FHI Clinical Inc. Expands Support in PREVAIL Research Network
FHI Clinical Inc. has announced that it has expanded its support role in the PREVAIL clinical research network, or Partnership for Research on Vaccines and Infectious Diseases in Liberia, to include full operational management. The goal is to sustain the ability of the network’s research-ready sites to conduct research in collaboration with sponsors and research teams, with a focus on emergent and high-impact public health research priorities in Liberia.
FHI Clinical oversees and facilitates the execution and contractual requirements of in-country logistics. These tasks include sourcing, procuring and shipping; all staff hiring; staff training, including good clinical practice, laboratory practices, data management, computer skills, record keeping, etc.; facility management; and renovation project management.
The research network was originally established in 2014 by the Liberian Ministry of Health and U.S. Department of Health and Human Services in response to the 2014-2015 Ebola outbreak.
To read the full release, click here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
